Alexandra Bolos

Dr. Alexandra Bolos

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 February 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MSMarco Solmi
Marco Solmi
AEAndrés Estradé
Andrés Estradé
TTTrevor Thompson
Trevor Thompson
AAAgorastos Agorastos
Agorastos Agorastos
JRJoaquim Radua
Joaquim Radua
CCChristoph U. Correll
Christoph U. Correll

9 April 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Cristina Gabriela SchiopuCristina Gabriela Schiopu
Cristina Gabriela Schiopu
Gabriela StefanescuGabriela Stefanescu
Gabriela Stefanescu
SDSmaranda Diaconescu
Smaranda Diaconescu
GBGheorghe Bălan
Gheorghe Bălan
NGNicoleta Gimiga
Nicoleta Gimiga
CSCristinel Stefanescu
Cristinel Stefanescu
Magnesium orotate has been cited in the medical literature for the past three years as a possible adjuvant in some pediatric and adult gastroenterological disorders associated with dysbiosis. Studies also focus on the possibility of adding magnesium orotate in psychiatric disorders’ treatment, such as major depression and anxiety. The most relevant element in these studies is the efficiency of magnesium orotate therapy in cases with both gastroenterological and psychiatric symptoms. This article proposes a literature review, focused on the studies published in the last three years, targeting magnesium orotate treatment and probiotic supplementation in patients with both digestive and psychiatric symptoms. Moreover, this review will compare the efficiency of magnesium orotate and probiotics within both the pediatric and adult communities, focusing on the possibility of gut–brain axis modulation and its involvement in the clinical evolution of these patients.

17 March 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Marcel Alexandru GainaMarcel Alexandru Gaina
Marcel Alexandru Gaina
ASAndreea Silvana Szalontay
Andreea Silvana Szalontay
Gabriela StefanescuGabriela Stefanescu
Gabriela Stefanescu
GBGheorghe Balan
Gheorghe Balan
CGCristina Mihaela Ghiciuc
Cristina Mihaela Ghiciuc
CȘCristinel Ștefănescu
Cristinel Ștefănescu
Background: Colonoscopy related fear impairs the current gold standard screening of colorectal cancer. Compared to other minimally invasive procedures for cancer screening, colonoscopy-induced anxiety exceeds the procedure through bowel preparation. Immersive virtual reality’s (iVR) role in alleviating the complex stress–pain relationship encountered during medical procedures is directly proportional to the rising affordability of state-of-the-art Head-Mounted-Displays (HMDs). Objective: to assess the effect of iVR on patients’ colonoscopy-induced anxiety and pain. Materials and methods: A systematic search was conducted in PubMed, Cochrane Central Register of Controlled Trials, Web of Science, Embase and Scopus databases up to January 2022. Clinical trials evaluating anxiety as an outcome were included without language restriction. Results: Four clinical trials were included: three on the patients’ intraprocedural anxiety and one on patient education. Intraprocedural iVR interventions for colonoscopy-induced anxiety and pain revealed a similar effect as conventional sedation, while a statistically significant reduction was reported for non-sedated patients. iVR patient education improved the quality of bowel preparation and reduced patient anxiety before colonoscopy. Conclusions: The current research highlights the need to use high-end HMDs and appropriate interactive iVR software content for colonoscopy-induced anxiety. Methodological frameworks regarding the eligibility of participants, double-blinding and randomization of iVR studies can facilitate the development of iVR implementation for anxiety and pain management.

23 May 2024 in Psychiatry Research
Verified
Journal Article
Open access
MSMarco Solm
Marco Solm
TTTrevor Thompson
Trevor Thompson
AEAndrés Estradé
Andrés Estradé
AAAgorastos Agorastos
Agorastos Agorastos
JRJoaquim Radua
Joaquim Radua
CCChristoph Correll
Christoph Correll
International studies measuring wellbeing/multidimensional mental health before/ during the COVID-19 pandemic, including representative samples for >2 years, identifying risk groups and coping strategies are lacking. COH-FIT is an online, international, anonymous survey measuring changes in well-being (WHO-5) and a composite psychopathology P-score, and their associations with COVID-19 deaths/restrictions, 12 a-priori defined risk individual/cumulative factors, and coping strategies during COVID-19 pandemic (26/04/2020-26/06/2022) in 30 languages (representative, weighted non-representative, adults). T-test, χ2, penalized cubic splines, linear regression, correlation analyses were conducted. Analyzing 121,066/142,364 initiated surveys, WHO-5/P-score worsened intra-pandemic by 11.1±21.1/13.2±17.9 points (effect size d=0.50/0.60) (comparable results in representative/weighted non-probability samples). Persons with WHO-5 scores indicative of depression screening (<50, 13% to 32%) and major depression (2 years. The most subjectively effective coping strategies were exercise and walking, internet use, social contacts. Identified risk groups, coping strategies and outcome trajectories can inform global public health strategies.

7 November 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Cristina Gabriela SchiopuCristina Gabriela Schiopu
Cristina Gabriela Schiopu
CSCristinel Stefanescu
Cristinel Stefanescu
ABAlexandra Bolos
Alexandra Bolos
SDSmaranda Diaconescu
Smaranda Diaconescu
GGGeorgiana-Emmanuela Gilca-Blanariu
Georgiana-Emmanuela Gilca-Blanariu
Gabriela StefanescuGabriela Stefanescu
Gabriela Stefanescu
Functional Gastrointestinal Disorders have been an important cause of poor life quality in affected populations. The unclear etiology and pathophysiological mechanism alter the clinical evolution of the patient. Although a strong connection with psychological stress has been observed, it was not until recently that the gut–brain axis involvement has been revealed. Furthermore, the current literature not only promotes the gut–brain axis modulation as a therapeutical target for functional digestive disorders but also states that the gut microbiome has a main role in this bi-directional mechanism. Psychiatric symptoms are currently recognized as an equally important aspect of the clinical manifestation and modulation of both the digestive and central nervous systems and could be the best approach in restoring the balance. As such, this article proposes a detailed description of the physiology of the microbiome–gut–brain axis, the pathophysiology of the functional gastrointestinal disorders with psychiatric symptoms and current perspectives for therapeutical management, as revealed by the latest studies in the scientific literature.